Generic Flexeril ( Сyclobenzaprine hcl )

Buy Generic Flexeril (Сyclobenzaprine hcl) without prescription in Canada

Flexeril (Cyclobenzaprine HCl 15 mg): Comprehensive Patient Information for Canada

Basic Product Information

Mechanism of Action

In simple terms: Flexeril is a muscle relaxant that works in the brain and spinal cord to reduce muscle spasms. It helps relax the muscles that have tightened up due to injury or strain, which reduces pain and stiffness. It works best when combined with rest and physical therapy. It does not work directly on the muscles themselves and does not affect normal muscle function.

For specialists: Cyclobenzaprine relieves skeletal muscle spasm of local origin without interfering with muscle function. It is ineffective in muscle spasm due to central nervous system disease. Animal studies indicate that cyclobenzaprine acts primarily within the central nervous system at the brain stem as opposed to the spinal cord level, although an overlapping action on the latter may contribute to its overall skeletal muscle relaxant activity. Evidence suggests that the net effect of cyclobenzaprine is a reduction of tonic somatic motor activity, influencing both gamma (γ) and alpha (α) motor systems. Pharmacological studies in animals showed a similarity between the effects of cyclobenzaprine and the structurally related tricyclic antidepressants, including reserpine antagonism, norepinephrine potentiation, potent peripheral and central anticholinergic effects, and sedation.

Pharmacokinetics

• Absorption: Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%. Cyclobenzaprine exhibits linear pharmacokinetics over the dose range 2.5 mg to 10 mg. The extended-release 15 mg capsule and 30 mg capsule have similar half-lives and time to peak plasma concentration.
• Metabolism: Cyclobenzaprine is extensively metabolized, and is excreted primarily as glucuronides via the kidney. Cytochromes P-450 3A4, 1A2, and, to a lesser extent, 2D6, mediate N-demethylation, one of the oxidative pathways for cyclobenzaprine. It is subject to enterohepatic circulation and is highly bound to plasma proteins.
• Elimination: Cyclobenzaprine is eliminated quite slowly, with an effective half-life of 18 hours (range 8 to 37 hours; n = 18); plasma clearance is 0.7 L/min. Drug accumulates when dosed three times a day, reaching steady-state within 3 to 4 days at plasma concentrations about four-fold higher than after a single dose. The elimination half-life is approximately 32 hours (range 8–37 hours).
• Onset of Action: Symptom relief typically begins within the first few days of treatment. The extended-release capsule is designed to provide once-daily dosing.
• Duration of Action: With a mean half-life of 18–32 hours, the extended-release 15 mg capsule supports once-daily dosing. The immediate-release tablet is typically dosed three times daily.

Uses in Daily Life and Best Practice Advice

Cyclobenzaprine is prescribed in Canada as an adjunct to rest and physical therapy for the short-term relief of muscle spasm associated with acute, painful musculoskeletal conditions. Your physician will determine the appropriate use and dose based on your specific situation.

• Typical Uses: Relief of muscle spasm associated with acute, painful musculoskeletal conditions, such as acute low back pain or neck pain. It is not intended for long-term use.
• Administration: The extended-release capsule (15 mg) is taken once daily, with or without food. Swallow the extended-release capsule whole; do not crush, chew, or open it. Alternatively, the capsule contents may be sprinkled on a tablespoon of applesauce and swallowed immediately without chewing.
• Monitoring: If your condition lasts after 2 to 3 weeks or if it gets worse, tell your doctor. Do not use this medication for longer than 2 to 3 weeks without medical advice.
• Do Not Stop Without Medical Advice: Do not stop taking this medication without consulting your physician.

Morning vs. Evening Dosing

Cyclobenzaprine extended-release capsules are typically taken once daily. There is no specific clinical recommendation for morning versus evening dosing. However, because drowsiness is a common side effect, taking the dose in the evening may help minimize daytime sedation. Always follow the schedule recommended by your physician.

• Once Daily (Extended-Release): The 15 mg extended-release capsule is taken once daily.
• Consistency: It is recommended to take the dose at approximately the same time each day.
• Missed Dose: If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not take two doses at the same time.
• Professional Guidance: Your healthcare provider may adjust the timing based on your response to treatment.

Administration With or Without Food

Cyclobenzaprine can be taken with or without food. Food does not significantly affect the absorption of cyclobenzaprine. This flexibility makes it convenient to take at any time of day.

• Take the extended-release capsule with a full glass of water.
• Swallow the extended-release capsule whole. Do not crush, chew, or open the capsule, as this may affect the release of the medication.
• If you have difficulty swallowing the capsule, the contents may be sprinkled on a tablespoon of applesauce and swallowed immediately without chewing.
• Avoid drinking alcohol while taking cyclobenzaprine, as it can increase drowsiness and impair thinking and coordination.

Interaction Warnings

Indications for Cyclobenzaprine

"Off-label" means use outside the official approved indication, usually based on current medical guidelines and scientific evidence.

Dosing According to Clinical Indication

Doses should always be adjusted according to the advice of your physician and depending on your health condition. Do not use cyclobenzaprine for longer than 2 to 3 weeks without medical advice. The recommended duration of therapy is short-term only. In a clinical study, cyclobenzaprine 5 mg three times daily was similarly effective to 10 mg three times daily for acute low back or neck pain, with fewer adverse events at the lower dose.

Side Effects and Safety Profile

Guidelines for Correct Use

• Take cyclobenzaprine exactly as prescribed by your physician. Do not change your dose without medical advice.
• Take the extended-release capsule (15 mg) once daily, with or without food. Swallow it whole; do not crush, chew, or open the capsule.
• If you have difficulty swallowing the capsule, the contents may be sprinkled on a tablespoon of applesauce and swallowed immediately without chewing.
• Do not use this medication for longer than 2 to 3 weeks without consulting your physician.
• Do not drink alcohol while taking cyclobenzaprine, as it can increase drowsiness and impair thinking and coordination.
• Do not drive or operate machinery until you know how cyclobenzaprine affects you.
• If you are pregnant, planning to become pregnant, or breastfeeding, consult your physician before use.
• If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose. Do not double the dose.
• Store at room temperature, protect from light and moisture, and keep out of reach of children.

Alternative Treatment Options

• Baclofen (Lioresal): A muscle relaxant that acts on the spinal cord. Available in 10 mg and 20 mg tablets. Often used for muscle spasticity associated with neurological conditions.
• Tizanidine (Zanaflex): A centrally acting muscle relaxant available in 4 mg tablets. Used for muscle spasticity and spasm. May cause drowsiness and dry mouth.
• Methocarbamol (Robaxin): A muscle relaxant available in 500 mg and 750 mg tablets. Used for acute musculoskeletal pain. May cause drowsiness and dizziness.
• Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) (e.g., ibuprofen, naproxen): Used for pain and inflammation associated with musculoskeletal conditions. May be used alone or in combination with muscle relaxants.
• Acetaminophen: An analgesic for pain relief. May be used alone or in combination with other therapies.

Comparison: Cyclobenzaprine is a commonly used muscle relaxant for acute musculoskeletal pain. It is structurally related to tricyclic antidepressants and has significant anticholinergic effects and sedative properties. Compared with other muscle relaxants such as baclofen and tizanidine, cyclobenzaprine is more likely to cause drowsiness and dry mouth. It is generally used for short-term therapy (2 to 3 weeks). Your physician will determine the best option for your specific condition.

Legal Status, Registration, and Coverage in Canada

• Registration: Cyclobenzaprine hydrochloride is authorized for sale in Canada by Health Canada as a prescription drug. The brand-name Flexeril is authorized in Canada (DIN 02495422). Numerous generic formulations are available in 10 mg tablets from manufacturers including Apotex (Apo-Cyclobenzaprine, DIN 02177145), Auro Pharma (Auro-Cyclobenzaprine, DIN 02348853), Sanis Health (Cyclobenzaprine Sanis, DIN 02287064), Sivem Pharmaceuticals (Cyclobenzaprine Sivem, DIN 02424584), Pro Doc Limitée (Cyclobenzaprine-10, DIN 02220644), Jamp Pharma (Jamp-Cyclobenzaprine, DIN 02357127), Pharmascience (PMS-Cyclobenzaprine, DIN 02212048), Riva (Riva-Cyclobenzaprine, DIN 02242079), and Teva Canada (Teva-Cyclobenzaprine, DIN 02080052). The extended-release capsule (Amrix) is available in 15 mg and 30 mg strengths.
• Prescription Status: Prescription only in Canada.
• Coverage: Coverage varies by province and territory. In Quebec, cyclobenzaprine is covered under the RAMQ formulary. In Ontario, Flexeril is listed as "Not a Benefit" on the Ontario Drug Benefit (ODB) formulary. Generic formulations may be covered under limited use criteria. In Newfoundland and Labrador, Teva-Cyclobenzaprine, PMS-Cyclobenzaprine, Auro-Cyclobenzaprine, and Jamp-Cyclobenzaprine are covered under the provincial drug plan. Generic formulations are generally more affordable than brand-name products.
• Pharmacovigilance: Adverse reactions should be reported to Health Canada's MedEffect Canada program at 1-866-234-2345.

Recent Research and Clinical Guidelines (2022–2026)

• Clinical guidance for acute low back or neck pain recommends prescribing a low dose of cyclobenzaprine for a short duration (e.g., 5 mg three times daily for 7 days). Over 7 days, cyclobenzaprine 5 mg three times daily was similarly effective to 10 mg three times daily. The 5 mg dose regimen was associated with less adverse events (e.g., somnolence, dry mouth) compared to the 10 mg dose regimen.
• The recommended duration of therapy remains short-term (2 to 3 weeks or less). Use of this medication is not recommended for periods longer than 2 or 3 weeks.
• Health Canada continues to classify cyclobenzaprine as a prescription drug. The brand-name Flexeril is authorized in Canada.
• Research continues to explore the role of cyclobenzaprine in the management of acute musculoskeletal pain, with a focus on optimizing dosing and minimizing side effects. The extended-release formulation (Amrix) provides once-daily dosing convenience.
• Drug shortage reports indicate that TEVA-CYCLOBENZAPRINE 10 mg tablets have experienced supply disruptions, with a shortage report filed in February 2025.

Availability and Supply in Canada

Prices and availability may vary by province, territory, and pharmacy. Generic cyclobenzaprine 10 mg tablets are widely available in Canada and are generally more affordable than the brand-name product. The extended-release 15 mg and 30 mg capsules (Amrix) may be subject to availability constraints. A drug shortage of TEVA-CYCLOBENZAPRINE 10 mg tablets was reported in February 2025. Check with your local pharmacy for current pricing and availability.

Frequently Asked Questions (FAQ)

1. What is Flexeril used for?
   Flexeril (cyclobenzaprine) is used along with rest and physical therapy for the short-term relief of muscle spasm associated with acute, painful musculoskeletal conditions, such as back pain and neck strain.
2. How long can I take cyclobenzaprine?
   The recommended duration of therapy is short-term (2 to 3 weeks or less). Do not use this medication for longer than 2 to 3 weeks without consulting your physician.
3. What is the difference between cyclobenzaprine 10 mg and 15 mg?
   The 10 mg formulation is an immediate-release tablet typically taken three times daily. The 15 mg formulation is an extended-release capsule (Amrix) taken once daily. The 15 mg extended-release capsule is designed to provide a more convenient once-daily dosing option.
4. Can I take cyclobenzaprine with food?
   Yes. Cyclobenzaprine can be taken with or without food. Food does not significantly affect the absorption of the medication.
5. What should I do if I miss a dose?
   If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not take two doses at the same time.
6. Can I drink alcohol while taking cyclobenzaprine?
   No. Alcohol should not be consumed while taking cyclobenzaprine because it can increase drowsiness and impair thinking and physical response times.
7. What are the serious side effects of cyclobenzaprine?
   Serious side effects include cardiovascular events (heart attack or stroke), serotonin syndrome, and severe allergic reactions. Seek immediate medical attention if you experience chest pain, shortness of breath, signs of a stroke, or symptoms such as agitation, hallucinations, rapid heart rate, fever, and muscle twitching.
8. Is cyclobenzaprine safe during pregnancy?
   Cyclobenzaprine should be used during pregnancy only if clearly needed. It is not known if this drug will harm an unborn baby. Consult your physician if you are pregnant or planning to become pregnant.
9. Is cyclobenzaprine safe during breastfeeding?
   It is not known if cyclobenzaprine passes into breast milk. You and your healthcare provider should decide if you will take this drug or breastfeed. Consult your physician before use.
10. Are there generic versions of cyclobenzaprine available in Canada?
    Yes. Generic cyclobenzaprine 10 mg tablets are widely available in Canada from multiple manufacturers, including Apotex, Auro Pharma, Sanis Health, Sivem Pharmaceuticals, Pro Doc Limitée, Jamp Pharma, Pharmascience, Riva, and Teva Canada. Generic versions are generally more affordable than the brand-name product.
11. Is Flexeril covered by Canadian health insurance?
    Coverage varies by province and territory. In Ontario, Flexeril is listed as "Not a Benefit" on the ODB formulary. In Quebec, cyclobenzaprine is covered under the RAMQ formulary. In Newfoundland and Labrador, several generic formulations are covered under the provincial drug plan. Check with your provincial drug plan and private insurance provider for coverage details.